Cargando…
The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma
Our non-tube no fasting (early oral feeding and no nasogastric tube) fast-track surgery (FTS) was safe and effective to combine with neoadjuvant chemotherapy for McKeown minimally invasive esophagectomy. In addition, the two groups were similar in terms of the recovery time, hospital discharge day,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472249/ https://www.ncbi.nlm.nih.gov/pubmed/36119515 http://dx.doi.org/10.3389/fonc.2022.906439 |
_version_ | 1784789267081330688 |
---|---|
author | Zheng, Yan Hao, Wentao Li, Yin Liu, Xianben Wang, Zongfei Sun, Haibo Liu, Shilei Xing, Wenqun |
author_facet | Zheng, Yan Hao, Wentao Li, Yin Liu, Xianben Wang, Zongfei Sun, Haibo Liu, Shilei Xing, Wenqun |
author_sort | Zheng, Yan |
collection | PubMed |
description | Our non-tube no fasting (early oral feeding and no nasogastric tube) fast-track surgery (FTS) was safe and effective to combine with neoadjuvant chemotherapy for McKeown minimally invasive esophagectomy. In addition, the two groups were similar in terms of the recovery time, hospital discharge day, and early resumption of oral feeding. OBJECTIVES: To evaluate the safety of early oral feeding (EOF) combined with neoadjuvant chemotherapy (NAC) of esophagectomy. SUMMARY BACKGROUND DATA: Our non-tube no fasting (early oral feeding and no nasogastric tube) fast-track surgery (FTS) was safe and effective for primary surgery esophageal cancer patients. METHODS: We retrospectively evaluated consecutive patients who underwent non-tube no fasting and McKeown minimally invasive (MIE). They were divided into two groups: one received NAC, and the other received primary surgery. Complications after the operation, postoperative CRG complications, operative time, operative bleeding, and length of stay were evaluated. RESULTS: Between 01/2014 and 12/2017, there hundred and eighty two consecutive patients underwent MIE with total two-field lymphadenectomy under the non-tube no fasting fast-track surgery program. A total of 137 patients received NAC, and 245 accepted primary surgery. Propensity score matching was used to compare NAC patients with 62 matched patients from each group. The NAC group had a similar number of total complications as the primary surgery group (32.26% in the primary surgery group vs. 25.81% in the NAC group; p=0.429) and had the same median postoperative hospitalization duration (8 days, p=0.723). CONCLUSIONS: After McKeown MIE, the patients receiving NAC combined with “non-tube no fasting” FTS had a similar incidence of postoperative complications outcomes as those without NAC. In addition, the two groups were similar in terms of the recovery time, hospital discharge day, and early resumption of oral feeding. |
format | Online Article Text |
id | pubmed-9472249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94722492022-09-15 The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma Zheng, Yan Hao, Wentao Li, Yin Liu, Xianben Wang, Zongfei Sun, Haibo Liu, Shilei Xing, Wenqun Front Oncol Oncology Our non-tube no fasting (early oral feeding and no nasogastric tube) fast-track surgery (FTS) was safe and effective to combine with neoadjuvant chemotherapy for McKeown minimally invasive esophagectomy. In addition, the two groups were similar in terms of the recovery time, hospital discharge day, and early resumption of oral feeding. OBJECTIVES: To evaluate the safety of early oral feeding (EOF) combined with neoadjuvant chemotherapy (NAC) of esophagectomy. SUMMARY BACKGROUND DATA: Our non-tube no fasting (early oral feeding and no nasogastric tube) fast-track surgery (FTS) was safe and effective for primary surgery esophageal cancer patients. METHODS: We retrospectively evaluated consecutive patients who underwent non-tube no fasting and McKeown minimally invasive (MIE). They were divided into two groups: one received NAC, and the other received primary surgery. Complications after the operation, postoperative CRG complications, operative time, operative bleeding, and length of stay were evaluated. RESULTS: Between 01/2014 and 12/2017, there hundred and eighty two consecutive patients underwent MIE with total two-field lymphadenectomy under the non-tube no fasting fast-track surgery program. A total of 137 patients received NAC, and 245 accepted primary surgery. Propensity score matching was used to compare NAC patients with 62 matched patients from each group. The NAC group had a similar number of total complications as the primary surgery group (32.26% in the primary surgery group vs. 25.81% in the NAC group; p=0.429) and had the same median postoperative hospitalization duration (8 days, p=0.723). CONCLUSIONS: After McKeown MIE, the patients receiving NAC combined with “non-tube no fasting” FTS had a similar incidence of postoperative complications outcomes as those without NAC. In addition, the two groups were similar in terms of the recovery time, hospital discharge day, and early resumption of oral feeding. Frontiers Media S.A. 2022-08-31 /pmc/articles/PMC9472249/ /pubmed/36119515 http://dx.doi.org/10.3389/fonc.2022.906439 Text en Copyright © 2022 Zheng, Hao, Li, Liu, Wang, Sun, Liu and Xing https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zheng, Yan Hao, Wentao Li, Yin Liu, Xianben Wang, Zongfei Sun, Haibo Liu, Shilei Xing, Wenqun The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma |
title | The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma |
title_full | The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma |
title_fullStr | The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma |
title_full_unstemmed | The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma |
title_short | The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma |
title_sort | safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472249/ https://www.ncbi.nlm.nih.gov/pubmed/36119515 http://dx.doi.org/10.3389/fonc.2022.906439 |
work_keys_str_mv | AT zhengyan thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT haowentao thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT liyin thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT liuxianben thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT wangzongfei thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT sunhaibo thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT liushilei thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT xingwenqun thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT zhengyan safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT haowentao safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT liyin safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT liuxianben safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT wangzongfei safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT sunhaibo safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT liushilei safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma AT xingwenqun safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma |